Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Down 79.8% in February

Azitra, Inc. (NYSEAMERICAN:AZTR) was the target of a large decrease in short interest in February. As of February 27th, there was short interest totaling 123,961 shares, a decrease of 79.8% from the February 12th total of 613,712 shares. Approximately 1.2% of the company’s shares are short sold. Based on an average trading volume of 1,520,219 shares, the short-interest ratio is presently 0.1 days. Based on an average trading volume of 1,520,219 shares, the short-interest ratio is presently 0.1 days. Approximately 1.2% of the company’s shares are short sold.

Azitra Stock Performance

Shares of NYSEAMERICAN:AZTR traded up $0.00 during trading on Tuesday, reaching $0.21. 1,612,189 shares of the company were exchanged, compared to its average volume of 1,705,374. The business’s fifty day simple moving average is $0.24 and its 200-day simple moving average is $0.45. Azitra has a 12-month low of $0.15 and a 12-month high of $2.66.

Azitra Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.